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Objective: Type D personality has been proposed as a risk factor for poor prognosis in cardiac patients. Recent
studies which have adopted a dimensional approach to Type D (negative affectivity×social inhibition) found
no effect of Type D on mortality, after controlling for its constituent elements. To-date, no study has deter-
mined if Type D is associated with psychosocial outcomes in post-myocardial infarction (MI) patients
when conceptualised as a dimensional variable.
Methods: Participants were 192 MI patients (138 males, 54 females, mean age 66.0 years) who provided de-
mographic and clinical information, and completed measures of Type D one-week post-MI. Three months
later, 131 of these MI patients completed measures of disability and quality of life.
Results: Using regression analyses, adjusted for demographic and clinical data, Type D emerged as a signiﬁ-
cant predictor of disability and quality of life in MI patients, when analysed using the traditional categorical
approach. However, Type D did not predict disability and quality of life when it was analysed using the inter-
action of negative affectivity and social inhibition. Negative affect emerged as a signiﬁcant predictor of both
disability (β=.433, t(130)=3.53, pb .01), and quality of life (β=− .624, t(130)=−5.68, pb .001).
Conclusions: The results suggest that Type D is not associated with short-term psychosocial outcome in MI pa-
tients, after controlling for its constituent elements. However, negative affect was signiﬁcantly associated
with both disability and quality of life. Future research should conceptualise Type D as the interaction be-
tween negative affectivity and social inhibition, rather than as a typology.© 2012 Elsevier Inc. All rights reserved.Introduction
The Type D construct describes individuals who simultaneously
experience high levels of negative affectivity and high levels of social
inhibition [1]. Type D individuals are, therefore, thought to experience
negative emotions (such as anxiety, sadness, anger etc.) across time
and situations and inhibit the expression of these emotions in social
interactions due to fears of how others may react. Crucially, it is the
synergistic effect of high scores on both stable personality traits, neg-
ative affectivity and social inhibition, which has been proposed as the
key feature of the Type D construct, suggesting that it is notmerely the
presence of negative emotions that should be considered as a risk fac-
tor but also how an individual copes with these negative emotions [2].
The ﬁrst studies carried out on the Type D construct [1,3,4] dem-
onstrated that Type D is associated with a four-fold increased risk of
mortality in coronary heart disease (CHD) patients, independent of
traditional biomedical risk factors. In addition, a further studyes, University of the West of
s).
rights reserved.demonstrated that Type D CHD patients had a four-fold risk of
major cardiac events over ﬁve years, independent of disease severity
[5]. Similar ﬁndings were demonstrated in recent studies which dem-
onstrated a comparable relationship between Type D and mortality in
patients with chronic heart failure (CHF) [6] and peripheral arterial
disease (PAD) [7]. A further study found that Type D predicts death
and recurrent MI in patients with acute MI after controlling for both
disease and depression severity [8]. However, these studies have re-
cently been criticised [9] on the basis of their small sample sizes
and over ﬁtted regression equations (given the relatively small num-
ber of deaths). Three recent studies have failed to ﬁnd an association
between the Type D typology and outcome [10–12]. However, these
studies are also limited by small sample sizes, and the number of
deaths being predicted.
The vast majority of research on Type D has utilised Type D as a di-
chotomous typology. Traditionally, individuals have been deﬁned as
Type D if they score ≥10 on both the NA and SI subscales of Type D
[13]. Recently, a taxometric analysis of Type D [14] has suggested
that Type D is better represented as a continuous rather than dichoto-
mous construct. Accordingly, the most appropriate test of the predic-
tive utility of Type D is to determine if the multiplicative interaction
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controlling for themain effects of the negative affectivity and social in-
hibition constituent elements in a regression analysis. Denollet has
proposed that the Type D construct is more than just the presence of
negative emotions and that social inhibition is a moderator of the
effects of negative affectivity on clinical outcome [1]. Accordingly,
analysing Type D as the interaction of negative affectivity×social inhi-
bition is arguably the most appropriate analytic method for the con-
struct, and provides the most stringent test of its predictive utility.
Several studies have now examined the utility of the multiplica-
tive term (i.e., negative affectivity×social inhibition) in predicting
outcome, after controlling for the main effects of the individual com-
ponents. In doing so, two large-scale studies [15,16] failed to ﬁnd an
association between Type D and mortality in cardiac patients. Coyne
et al. [15] investigated the prognostic value of Type D on mortality
in a large sample of Chronic Heart Failure (CHF) patients, and found
that Type D did not predict mortality at 18-month follow-up. Similar-
ly, Grande et al. [16] found no association between Type D and all-
cause-mortality in a large sample of German cardiac patients at 6-
year follow-up. These studies have the advantage over previous
research on Type D in terms of their large samples. However, Coyne
et al.'s study is based on a relatively short follow-up period in terms
of mortality, and the sample consists of an unusually low prevalence
of Type D (13%, compared to rates of 25–30% that are typically ob-
served). In addition, the study by Grande et al. only uses all-cause-
mortality as an outcome (as opposed to cardiac mortality with
which Type D has been most closely related). However, these studies
have cast doubt on the association between Type D and mortality in
cardiac patients. Furthermore, a recent meta-analysis [17] has sug-
gested that the early studies on Type D may have overestimated the
prognostic effect of Type D. Although the authors identiﬁed a signiﬁ-
cant association between Type D and mortality and non-fatal MI, they
found that the identiﬁed odds ratios have decreased over time.
A large body of evidence has suggested a link between Type D and
subjective health (including impaired physical health, increased
symptoms of depression and anxiety, and lower quality of life) in
CHF patients and those with peripheral arterial disease (PAD)
[18–22]. Studies have also demonstrated the usefulness of the Type
D construct in predicting subjective outcomes in post-MI patients.
One study investigated whether Type D predicted disease-speciﬁc
health status 18 months post-MI [23]. It found that Type D patients
had signiﬁcantly more physical limitations, and less angina stability
than non-Type D patients. Thus far, only one study has failed to ﬁnd
an association between Type D and health status [10].
Evidence therefore suggests that Type D may be an important risk
factor for poor subjective outcomes in MI patients. However, to-date
all previous research on Type D and psychosocial outcomes has ana-
lysed Type D status using a categorical typology. Therefore, in line
with recent ﬁndings [15,16] it is important to examine if Type D is as-
sociated with subjective outcome when treated as a dimensional var-
iable in standard regression analyses, after controlling for the main
effects of negative affectivity and social inhibition. Accordingly, we
analysed the data from this study using two methods, ﬁrst using the
traditional method of classifying individuals as Type D if they scored
above the recommended cut-off (≥10) on both NA and SI. Second,
we treated both NA and SI as continuous variables and performed tra-
ditional regression analyses, testing whether the multiplicative term
of SI×NA explained additional variance in disability and quality of
life, after the entry of SI and NA individually.
Methods
Participants and procedure
Patients were invited to participate if they met the following
broad inclusion criteria: they had been admitted to hospital for aMI, and they had a satisfactory level of English to complete the ques-
tionnaires. The response rate at baseline was 97.5%, with ﬁve poten-
tial participants refusing to take part. A non-consecutive sample of
192 MI patients, who were admitted to Edinburgh Royal Inﬁrmary
(ERI) in Scotland, participated in the study. The mean age of the par-
ticipants was 66.0 (10.8) years (range 40–88 years). Women com-
prised 28.1% of the sample (n=54). With informed consent and
approval of the National Health Service (NHS) Ethical Committee,
the patients were asked to complete a research questionnaire while
they were in hospital and 3 months later. At the 3-month follow-up,
131 (63%) of the original 192 participants completed the follow-up
questionnaire. The mean age of the participants at follow-up was
65.89 (SD =10.76) years, and comprised of 39 females and 92
males. At baseline, patients completed measures of Type D personal-
ity, and provided demographic information. At 3 months, patients
completed measures of quality of life and disability.
Measures
Demographic and clinical variables
Socio-demographic variables included sex, age and socioeconomic
status. Socioeconomic status was measured by the deprivation scores
attached to an individual's postal code [24]. Baseline clinical variables,
including history of previous MI, and left ventricular function (LVF)
were measured. LVF was measured by means of echocardiography.
Type D personality
The Type D Personality Scale (DS14) [13] is a 14-item scale com-
prising of two subscales; a seven-item subscale which measures neg-
ative affectivity (e.g. ‘I often feel unhappy’), and a seven-item
subscale measuring social inhibition (e.g. ‘I often feel inhibited in so-
cial interactions’). Respondents rate their personality on a ﬁve-point
Likert-type scale which ranges from zero = false to four = true
(items one and three were reverse scored). The negative affectivity
and social inhibition scales can be scored as continuous variables
(range 0–28) to assess these personality traits independently. Tradi-
tionally, participants who scored highly on both negative affectivity
and social inhibition using a cut-off point of ≥10 on both scales
have been classiﬁed as having a Type D personality [13]. However,
more recently taxometric analyses have suggested that Type D
may be better represented as a dimensional construct, as the interac-
tion of continuous negative affectivity and social inhibition [14].
Cronbach's α=0.88 and 0.86, respectively, for negative affectivity
and social inhibition indicating excellent internal consistency in the
current sample.
Disability
The Functional Limitations Proﬁle (FLP) [25] is the British version
of the American Sickness Impact Proﬁle (SIP) [26]. The British version
translated the SIP into British English, renamed and rescored it to use
British item weights. The aim of the scale is to assess changes in func-
tion due to ill-health. The scale consists of 136 items within 12 cate-
gories of activity. Four categories were selected for use in the
current study, with a total of 49 items. These were ambulation, mobil-
ity, recreation and social interaction. Each category contains items
which describe a restriction in activity (e.g. I walk more slowly) and
the respondents are required to indicate whether the item applied
to them today and if it is due to their health. Administration of the
FLP was modiﬁed for use in the current study. Participants were
asked whether they agreed or disagreed with each statement. If
they agreed, they were asked; ‘Is this due to your health?’ If the par-
ticipant answered yes then they moved on to the next category of
items. Cronbach's α=0.81 for the composite score from the 4 abbre-
viated FLP scales indicating good internal consistency in the current
sample.
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Quality of life after myocardial infarction was assessed using the
MacNew [27]. This is a heart disease-speciﬁc health-related quality
of life instrument which assesses three major quality of life domains;
emotional (e.g. ‘In general, how much of the time during the last
2 weeks have you felt frustrated, impatient or angry’, physical (e.g.
‘How much shortness of breath have you experienced during the
last 2 weeks while doing your day-to-day activities’, and social (e.g.
‘How often during the last 2 weeks have you felt you were unable
to do your usual social activities, or social activities with your family’.
The instrument consists of 27 items, each with a seven-point Likert-
type response scale. Cronbach's α=0.95 for the overall measure, in-
dicating excellent internal consistency.
Statistical analyses
All statistical analyses were calculated using PASW Statistics 18.0
(SPSS Inc., Chicago, IL). First, we examined the prevalence of Type D
personality, and the relationship between Type D classiﬁcation and
the outcome variables (disability and quality of life). In addition, cor-
relation analyses were performed in order to examine the association
between the multiplicative interaction term of NA×SI and quality of
life and disability.
To investigate whether Type D statistically predicts disability and
quality of life, we employed two analytic strategies using hierarchical
multiple regression. First, we conducted the standard Type D ana-
lyses, operationalising Type D as a categorical variable. Therefore,
the ﬁrst set of hierarchical multiple regression analyses examined
whether Type D classiﬁcation was an independent predictor of Time
2 (T2) disability and quality of life, after controlling for demographic
and clinical variables. Second, we operationalised Type D as the inter-
action between the NA and SI dimensions (consistent with standard
moderation analyses [28]). Therefore, the second set of regressions
sought to examine whether the constituent components of Type D
(NA and SI) interact to predict T2 disability and quality of life, after
controlling for demographic and clinical data, and the constituent
components entered independently of one another. The later ap-
proach is in line with recent studies [15,16] and recommendations
[9,14]. In doing so, we are controlling for the main effects of the neg-
ative affectivity and social inhibition components. We chose to use
the hierarchical method as we had a clear rationale for determining
the order of entry for the variables. Demographic information was en-
tered ﬁrst as these factors are known risk factors. Clinical data was
entered in the second step so that we could identify whether Type
D (in the following step) has any predictive value after controlling
for these well established outcome predictors.
Results
Patient characteristics
Baseline clinical and demographic information is provided in Table 1. From the
sample of 192 participants, 65 (18 females and 47 males) were classiﬁed as Type D
(33.9%) using the recommended cut-off point of ≥10 on both negative affectivityTable 1
Patient information at baseline.
Characteristic Total
Age, M (SD), y 66.0 (10.8)
Women, % 28.1
Deprivation (1–7) (Mode) 4
Previous MI, % 27.1
Impaired LVF, % 41.1
NA, M (SD) 11.43 (5.87)
SI, M (SD) 10.85 (5.73)
Type D, % 33.9
M = mean; SD = standard deviation; MI = myocardial infarction; LVF = left ventric-
ular function; NA = negative affect; SI = social inhibition.(Mean=11.43; Median=9; SD=5.87) and social inhibition (Mean=10.85;
Median=10; SD=5.73) subscales [13]. This corresponds to 33.3% of females and
36.1% of males being categorized as having a Type D personality. There were no signif-
icant differences between the respondents and non-respondents (who did not com-
plete Time 2) in terms of age (t (1, 190)=−.042, ns), gender (χ² (2, N=192)=
.085, ns), deprivation category (χ² (7, N=192)=4.52, ns), MI severity as assessed
by LV function (χ² (4, N=192)=4.50, ns), or Type D personality (χ² (2, N=192)=
.292, ns).
Categorical analysis
Using the traditional Type D cut-off points it was found that Type D individuals
(M=223.72, SD=58.0) scored signiﬁcantly higher than non-Type D individuals
(M=139.5, SD =59.0) on disability (t(1,129)=−7.85, pb0.001), indicating that
Type D individuals reported signiﬁcantly higher levels of disability than non-Type D
patients. In addition, Type D individuals (M=86.41, SD=18.85) scored signiﬁcantly
lower on quality of life than non-Type D individuals (M=122.17, SD=25.52), indicat-
ing that Type D individuals experience poorer quality of life than non-Type D's
(t(1,129)=8.34, pb0.001).
Type D personality as a predictor of disability at time two (categorical)
Demographic factors were entered in the step 1 of the multiple regression (i.e. sex,
age and deprivation), followed by medical factors (i.e. previous MI and LVF) in step 2.
Finally, Type D classiﬁcation was entered in the ﬁnal step. In the ﬁrst step, the inclusion
of sex, age and deprivation did not account for a signiﬁcant amount of T2 adherence, Δ
R2=0.037, ns and the combined effect of previous MI and LVF explained an additional
5.7% of the variance. Type D personality was a signiﬁcant predictor of disability in the
ﬁnal step β=.534, t(130)=6.94, pb .01 explaining an additional 25.3% of the variance.
Type D personality as a predictor of quality of life at time two
(categorical analysis)
In the ﬁrst step, the inclusion of sex, age and deprivation did not account for a sig-
niﬁcant amount of T2 adherence, Δ R2=0.068, ns and the combined effect of previous
MI and LVF explained an additional 10.2% of the variance. However, Type D personality
was a signiﬁcant predictor of quality of life in the ﬁnal step β=− .528, t(130)=−7.25,
pb .01 explaining an additional 24.7% of the variance.
Dimensional analysis
In order to examine the relationship between the Na×SI interaction term and the
outcome variables a correlation analysis was performed. Correlation analyses showed
that Type D (NA×SI) was positively correlated with higher levels of disability
(r=.52, pb .01), and inversely associated with quality of life (r=− .56, pb .01).
Type D personality as a predictor of disability at time two
(dimensional analysis)
Next, we conducted further hierarchical regressions to determine whether the in-
teraction between NA and SI predicted disability and quality of life. As above, we con-
trolled for the effects of demographic factors (i.e. sex, age and deprivation) in the ﬁrst
step of the hierarchical regression followed by medical factors (i.e. previous MI and
LVF) in step 2 (Table 2). Next, SI and NA were entered at step 3 followed by the
SI×NA interaction term at step 4. Both NA and SI showed acceptable levels of skew
and kurtosis for inclusion in the analysis.
As shown in Table 2, steps one and two accounted for circa 9.4% of the T2 disability
variance. At step three, negative affect, β=.433, t(130)=3.53, pb .01 but not social in-
hibition, β=.100, t(130)=.831, ns, was a signiﬁcant predictor of T2 disability, ac-
counting for 23.6% of the variance. In the ﬁnal model, the social inhibition×negative
affect interaction was non- signiﬁcant, β=.020, t(130)=.048, ns. Negative affect
remained the only signiﬁcant predictor in the ﬁnal model.
Type D personality as a predictor of quality of life at time two
(dimensional analysis)
The same regression analysis was repeated as above, utilising quality of life as the
criterion variable. As is evident in Table 3, steps one and two accounted for circa 17% of
the T2 quality of life variance. At step three, negative affect, β=− .624, t(130)=
−5.68, pb .001, but not social inhibition, β=.036, t(130)=.586, ns, was a signiﬁcant
predictor of T2 quality of life, accounting for 29.4% of the variance. In the ﬁnal model,
the social inhibition×negative affect interaction term was non-signiﬁcant, β=
− .001, t(130)=− .002, ns. Negative affect and LVF were signiﬁcant predictors in the
ﬁnal model.
Discussion
The current study found that Type D was signiﬁcantly associated
with disability and quality of life in MI patients, when analysed
Table 2
Hierarchical regression analyses predicting time 2 disability.
Step Variable β Δ R2 Total 95% CI
At step For step R2
Step 1 Sex −.010 −28.96–25.69
Age .146 −.19–2.02
Deprivation .095 .037 .037 −3.91–12.91
Step 2 Sex .015 −24.49–29.31
Age .151 −.15–2.03
Deprivation .076 −4.79–11.94
Previous MI .206⁎ 5.69–60.32
LVF .119 .057⁎ .094⁎ −4.05–22.5
Step 3 Sex −.021 −26.8–20.01
Age .034 −.76–1.18
Deprivation .038 −5.48–9.1
Previous MI .110 −6.78–41.92
LVF .075 −5.69–17.45
Social Inhibition .100 −1.72–4.2
Negative Affect .433⁎⁎ .236⁎⁎⁎ .330⁎⁎⁎ 2.39–8.5
Step 4 Sex −.021 −26.91–20.19
Age .033 −.78–1.19
Deprivation .038 −5.51–9.13
Previous MI .110 −6.88–42.09
LVF .075 −5.74–17.5
Social Inhibition .087 −6.18–8.34
Negative Affect .426⁎ .219–10.47
Social Inhibition×
Negative Affect
.020 .00 .330⁎⁎⁎ −.39–.42
⁎ pb .05.
⁎⁎ pb .01.
⁎⁎⁎ pb .001.
Table 3
Hierarchical regression analyses predicting time 2 quality of life.
Step Variable β Δ R2 Total 95% CI
At step For step R2
Step 1 Sex −.003 −11.16–10.75
Age −.159 −.85–.04
Deprivation −.171 .068⁎ .068⁎ −6.67–.08
Step 2 Sex −.040 −13.07–7.92
Age −.159 −.83–.02
Deprivation −.157 −6.3–.24
Previous MI −.235⁎⁎ −25.94 to −4.62
LVF −.214⁎ .102⁎⁎ .170⁎⁎⁎ −11.99 to −1.63
Step 3 Sex −.004 −8.77–8.31
Age −.029 −.43–.28
Deprivation −.124 −5.05–.27
Previous MI −.114 −16.34–1.42
LVF −.165⁎ −9.46 to −1.02
Social Inhibition .063 −.76–1.40
Negative Affect −.624⁎⁎⁎ .294⁎⁎⁎ .463⁎⁎⁎ −4.31 to −2.08
Step 4 Sex −.004 −8.82–8.36
Age −.029 −.43–.29
Deprivation −.124 −5.06–.29
Previous MI −.114 −16.39–1.47
LVF −.165⁎ −9.48 to −1.0
Social Inhibition .064 −2.33–2.97
Negative Affect −.624⁎⁎ −5.06 to −.32
Social Inhibition×
Negative Affect
−.001 .00 .463⁎⁎⁎ −.15–.15
⁎ pb .05.
⁎⁎ pb .01.
⁎⁎⁎ pb .001.
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idence that Type D personality was associated with disability and
quality of life when Type D was analysed using the interaction of neg-
ative affectivity and social inhibition. On the other hand, there was a
signiﬁcant main effect of negative affectivity on disability and quality
of life. These ﬁndings suggest that in the current study it is the nega-
tive affectivity component of Type D that is driving the relationship
between Type D and subjective outcome that was identiﬁed in the
ﬁrst categorical analyses.
Previous research has also identiﬁed a relationship between Type
D and subjective outcomes, when Type D was analysed as a dichoto-
mous typology. For example, research has shown that Type D MI pa-
tients have poorer quality of life than their non-Type D counterparts
[23]. However, these previous studies have failed to control for the
constituent components of Type D in their analyses. The current ﬁnd-
ings are also in line with two recent studies [15,16] that failed to ﬁnd
an association between Type D and mortality (when Type D was ana-
lysed as a continuous variable, in the same way as we have done
here).
All of the previous studies that have found evidence of a relation-
ship between Type D and prognosis (either mortality or subjective
outcomes) used Type D as a typology, i.e., Type D individuals were
found to have poorer outcome than non-Type D individuals. Howev-
er, to-date the small number of studies that have analysed Type D as a
continuous variable, and controlled for its constituent elements
[11,15,16], have found no effect of Type D outcome (with the excep-
tion of one study that found that negative affectivity×social inhibi-
tion predicted medication adherence after controlling for the main
effects of negative affectivity and social inhibition [29]).
The current study found that negative affectivity was signiﬁcantly
associated with both quality of life and disability. The negative affec-
tivity component of Type D has substantial overlap with similar con-
structs such as depression and neuroticism [15,30]. Given that there is
already a substantial basis of literature on the effects of negative emo-
tions on outcome in cardiac patients, it could be argued that the cur-
rent ﬁndings again point towards a focus on negative emotions as the
most useful path for future research to follow.Adopting Type D as a continuous variable also raises the possibil-
ity of proxy measures of Type D being utilised. For example, the inter-
action between neuroticism and introversion (facets of The Big Five)
would seem to represent an analogous measure to Type D (some the-
orists have also argued that the negative affectivity component of
Type D could be replaced with depression [15]. One advantage of
such an approach is that previous data sets that contain these mea-
sures could be re-analysed to determine if there is a moderating effect
of introversion on neuroticism in the context of clinical outcomes.
The present study is the ﬁrst to examine the relationship between
Type D and subjective outcomes in MI patients while using Type D as
a continuous variable. It also has the advantage of being one of few
studies performed out with the original Type D research group that
has examined the prognostic value of Type D in cardiac patients.
However, there are also several limitations of the present study that
should be acknowledged. First, the modest follow-up rate of 63%
may also be considered a limitation. Second, the participants repre-
sented a non-consecutive sample; however, we do not believe that
this had an impact in terms of selection bias, as the same inclusion
criteria were applied to all potential participants. Third, the associa-
tion between negative affect and quality of life should be interpreted
with caution. It is likely that there is substantial overlap between
these constructs which may explain the high regression coefﬁcient
that derives from this relationship. Finally, the study is limited to a
relatively short 3-month follow-up period. Future research is re-
quired which examines the inﬂuence of Type D on subjective out-
comes on a more long-term basis. It is possible that Type D may
exert more of a long-term inﬂuence on prognosis. As we did not as-
sess Time 1 disability and quality of life, we cannot infer causality re-
garding the relationship between Type D (or NA) and outcome.
Therefore, future research may wish to investigate the relationship
between Type D and residual change in disability/quality of life over
time.
In the current study, we found that when analysed as a dichoto-
mous typology Type D was associated with poorer quality of life
and greater disability in MI patients. However, additional regression
analyses using the interaction of negative affectivity and social
426 L. Williams et al. / Journal of Psychosomatic Research 72 (2012) 422–426inhibition found no evidence to support the utility of Type D in pre-
dicting subjective outcomes in MI patients. However, negative affec-
tivity was found to be signiﬁcant, and it is that component which
was driving the association between Type D and subjective outcomes
that was observed during the traditional categorical Type D analyses.
It is possible that it is the negative affectivity component of Type D
that has been driving the associations between Type D and subjective
outcomes that have been observed in previous studies. Future re-
search should analyse Type D as the interaction of negative affectivity
and social inhibition, and not as a dichotomous typology. Accordingly,
it would be prudent for existing data on Type D to be re-examined to
determine if the data support the utility of the interaction of negative
affectivity and social inhibition (as opposed to the Type D typology)
in predicting outcomes. The present ﬁndings pertain solely to a
post-MI population, and to short-term softer subjective outcomes. It
may be that Type D has greater predictive value in particular cardiac
patient groups, and for particular outcomes. Future research should
aim to uncover if there are speciﬁc groups and outcomes for which
Type D may be more important.
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